Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52.7M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1.49M
-
Shares change
-
+684K
-
Total reported value, excl. options
-
$4.47M
-
Value change
-
+$2.06M
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$3.01
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q4 2022
20 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q4 2022.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.49M shares
of 52.7M outstanding shares and own 2.82% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (690K shares), VANGUARD GROUP INC (270K shares), BlackRock Inc. (152K shares), AlphaCentric Advisors LLC (100K shares), DIMENSIONAL FUND ADVISORS LP (92.5K shares), GEODE CAPITAL MANAGEMENT, LLC (52.9K shares), MORGAN STANLEY (36.3K shares), STATE STREET CORP (26.1K shares), RENAISSANCE TECHNOLOGIES LLC (18K shares), and Bank of New York Mellon Corp (15.5K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.